Skip to main content
. 2024 Mar 2;22:227. doi: 10.1186/s12967-024-05016-x

Table 3.

Summary of findings from studies included in the meta-analysis and meta-regression

Study Subgroup No. Studies No. eyes Meta-analysis Meta-regression
Standardized MD 95%CI P-value Subgroup difference Variable estimate P-value
AMD Wet 2 5 − 1.74 − 2.91 to − 0.58  < 0.01  < 0.05 Publication year 0.35  < 0.05
Mean age 0.30  < 0.0001
Dry 10 135 − 0.26 − 0.73–0.22  < 0.01 Scaffold − 3.50  < 0.001
RPE 1.90  < 0.0001
NSC − 1.97  < 0.05
Overall 12 140 − 0.47 − 0.91 to − 0.03  < 0.05
BMSC 0.50 0.17
UPMSC − 1.16 0.11
SMD Overall 2 40 0.25 − 0.52–1.02 0.52 NA Publication year − 0.01 0.74
Mean age − 0.03  < 0.05
RPE 1.38 0.09
BMSC 1.24 0.15
RP Overall 2 44 0.41 0.16–0.67  < 0.01 NA NA NA NA

MD, mean difference; AMD, age-related macular degeneration; SMD, Stargardt’s macular dystrophy; RP, retinitis pigmentosa; RPE, retinal pigment epithelium; ESC, embryonic stem cell; NSC, neural stem cell; ASC, adult stem cell; BMSC, bone marrow mesenchymal stem cell; ADSC, adipose-derived mesenchymal stem cell; UMSC, umbilical cord mesenchymal stem cell